Avosentan

Salzburg, Austria, February 15: A study has found that a new drug called avosentan might be effective in slowing the progression of diabetic kidney disease and help prevent end stage

According to a study published online by the Journal of the American Society Nephrology, the drug appreciably lowers the amount of a protein called proteinuria, secreted in the urine. This protein is believed to be an important indicator of the diabetic kidney disease in the body, which is normally caused by uncontrolled diabetes.